GUWAHATI: Assam Medical College and Hospital (AMCH) in Dibrugarh has achieved a significant milestone in specialised healthcare by becoming the first centre in Northeast India to successfully administer Enzyme Replacement Therapy (ERT) using Valeglucerase Alpha to a three-and-a-half-year-old child diagnosed with a Lysosomal Storage Disorder (LSD).
ALSO READ: Assam Police Arrests 330 in Statewide Crackdown on Fraudsters and Impersonators
The treatment was administered by the Department of Paediatrics, led by Professor and Head Dr Arpita Gogoi, along with Dr Dorothy Gargo and a multidisciplinary team under AMCH’s Centre of Excellence (CoE) for Rare Diseases.
AMCH Principal Dr Sanjeeb Kakati said the achievement marks an important step towards improving access to specialised treatment for patients with rare genetic and metabolic disorders in Assam and the wider Northeast.
The successful administration of the therapy is also expected to strengthen the Centre of Excellence for Rare Diseases at AMCH, enabling it to expand its capacity to diagnose and manage rare genetic and metabolic conditions and facilitate access to specialised therapies for patients across the region.